# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001753926-25-001715
Filing Date
2025-11-07
Accepted
2025-11-07 08:01:54
Documents
23
Period of Report
2025-11-07
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | FORM 8K | g084989_8k.htm iXBRL | 8-K | 73703
2 | EXHIBIT 4.1 | g084989_ex4-1.htm | EX-4.1 | 277652
3 | EXHIBIT 10.1 | g084989_ex10-1.htm | EX-10.1 | 420652
4 | EXHIBIT 10.2 | g084989_ex10-2.htm | EX-10.2 | 77021
5 | EXHIBIT 10.3 | g084989_ex10-3.htm | EX-10.3 | 235128
6 | EXHIBIT 10.4 | g084989_ex10-4.htm | EX-10.4 | 47320
7 | EXHIBIT 10.5 | g084989_ex10-5.htm | EX-10.5 | 32008
8 | EXHIBIT 10.6 | g084989_ex10-6.htm | EX-10.6 | 20406
9 | EXHIBIT 10.7 | g084989_ex10-7.htm | EX-10.7 | 366536
10 | EXHIBIT 10.8 | g084989_ex10-8.htm | EX-10.8 | 372262
11 | EXHIBIT 99.1 | g084989_ex99-1.htm | EX-99.1 | 29227
15 | GRAPHIC | image_003.jpg | GRAPHIC | 2530
| Complete submission text file | 0001753926-25-001715.txt |  | 2514155

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
12 | XBRL SCHEMA FILE | pths-20251107.xsd | EX-101.SCH | 3011
13 | XBRL LABEL FILE | pths-20251107_lab.xml | EX-101.LAB | 34239
14 | XBRL PRESENTATION FILE | pths-20251107_pre.xml | EX-101.PRE | 22356
25 | EXTRACTED XBRL INSTANCE DOCUMENT | g084989_8k_htm.xml | XML | 3808

Mailing Address 4020 STIRRUP CREEK DRIVE SUITE 110 DURHAM NC 27703
Business Address 4020 STIRRUP CREEK DRIVE SUITE 110 DURHAM NC 27703 919-908-2422
Pelthos Therapeutics Inc. (Filer) CIK: 0001919246 (see all company filings)

EIN.: 863335449 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41964 | Film No.: 251460580
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)